Table 2.
Comparisons between subjects with and without comorbid ED in the PE group
| Variables | Subjects without comorbid ED (n = 337) | Subjects with comorbid ED (n = 146) | P value |
|---|---|---|---|
| Age, y | 41.5 ± 11.4 (20–76) | 48.9 ± 12.6 (20–76) | P <.001 |
| Obesity (BMI ≥ 27 kg/m2) | 21.7% (73) | 29.5% (43) | No significance |
| Diabetes mellitus | 4.2% (14) | 17.8% (26) | P <.001 |
| Hypertension | 8.6% (29) | 21.2% (31) | P <.001 |
| Dyslipidemia | 23.7% (80) | 52.7% (77) | P <.001 |
| MACE | 0.3% (1) | 3.4% (5) | P <.01 |
| Hypogonadism* | 19.9% (39) | 27.5% (30) | No significance |
| PE duration, y | 9.9 ± 10.4 (0–50) | 12.3 ± 13.2 (0.3–50) | P <.05 |
| Total PEDT score | 15.1 ± 3.6 (3.0–20.0) | 15.1 ± 3.8 (4.0–20.0) | No significance |
| PE types | |||
| Lifelong PE | 42.1% (142) | 27.4% (40) | P <.01 |
| Acquired PE | 37.7% (127) | 44.5% (65) | |
| Probable PE | 20.2% (68) | 28.1% (41) | |
| IELT, sec | 72.1 ± 68.3 (0–600.0) | 77.2 ± 64 (3.0–300.0) | No significance |
Abbreviations: BMI = body mass index, ED = erectile dysfunction, IELT = Intravaginal ejaculatory latency time, MACE = major adverse cardiovascular events, PE = premature ejaculation, PEDT = Premature Ejaculation Diagnostic Tool
⁎
Hypogonadism is defined as a serum total testosterone level below 348 ng/dL.